Search clinical trials for: mineralocorticoid receptor

Total 18115 results

Regional Hospital Holstebro

Completed

The Effects of Amiloride and Spironolactone on Renophysiological and Cardiovascular Variables (hass)

Essential Hypertension

Denmark
Hospital de Clinicas de Porto Alegre

Completed

Sodium-Restricted Diet and Diuretic in the Treatment of Severe Sleep Apnea (DESALT)

Obstructive Sleep Apnea

Brazil
Instituto Nacional de Ciencias Medicas y Nutricion...

Terminated

Use of Spironolactone for the Prevention of Electrolyte Abnormalities in Patients Treated With Amphotericin B

Patients With Fungic Infections

Mexico
Assistance Publique - Hôpitaux de Paris
Société de Dermatologie Française

Completed

Interest of Topical Spironolactone's Administration to Prevent Corticoid-induced Epidermal Atrophy (SPIREPI)

Cutaneous Atrophy Due to Corticosteroids

France
University of Cambridge
British Heart Foundation

Unknown

Optimum Treatment for Drug-Resistant Hypertension (PATHWAY2)

Hypertension, Resistant to Conventional Therapy

United Kingdom
Assistance Publique - Hôpitaux de Paris

Completed

Aldosterone Blockade Early After Acute Myocardial Infarction (ALBATROSS)

Myocardial Infarction

France
Monash University
National Heart Foundation, Australia

Completed

SCREEN-HFI (SCReening Evaluation of the Evolution of New Heart Failure Intervention Study)

Heart Failure

Australia
Washington University School of Medicine
University of Pennsylvania

Withdrawn

CLCNKA (Ka Renal Chloride Channel[ClC-Ka]) Polymorphism Effects on Hypertrophy Regression

Hypertension

United States
Bayer

Completed

Effects of Angeliq and Prempro on Blood Pressure and Sodium Sensitivity in Postmenopausal Women With Prehypertension

Hypertension | Postmenopause | Pre-Hypertension

United States
Texas Tech University Health Sciences Center

Withdrawn

Aliskiren and Renin Inhibition in Diastolic Heart Failure (ARID-HF)

Diastolic Heart Failure

United States
Baylor College of Medicine
National Heart, Lung, and Blood Institute (NHLBI)

Unknown

Effects of Spironolactone on Collagen Metabolism in Patients With Pulmonary Arterial Hypertension

Pulmonary Hypertension

United States
Bayer

Completed

Low-dose Hormone Therapy for Relief of Vasomotor Symptoms

Vasomotor Symptoms | Hot Flashes

United States
Sobngwi Eugene
University of Yaounde 1

Completed

Efficacy of Spironolactone in Cameroonian Diabetic Patients With Resistant Hypertension (SPIRY)

Diabetes Mellitus | Hypertension, Resistant to Conventional Therapy

Cameroon
Bayer

Completed

Cycle Control and Safety of E2-DRSP

Contraceptive, Oral, Hormonal

Germany
Instituto Nacional de Cardiologia Ignacio Chavez
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Unknown

Short Term Spironolactone for Prevention of Acute Kidney Injury After Cardiac Surgery

Kidney Injury, Acute | Acute Renal Injury | Acute Kidney Injuries | Kidney Injuries, Acute | Acute Renal Injuries

Mexico
Mahidol University

Unknown

Comparison of Body Weight Change During Contraception With Belara and Yasmin

Body Weight Changes

Thailand
HealthCore-NERI
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function (TOPCAT)

Heart Diseases | Cardiovascular Diseases | Heart Failure, Congestive

United States, Canada, Brazil, Argentina, Georgia, Russian Federation
University of Sao Paulo
Conselho Nacional de Desenvolvimento Científico e Tecnológico

Completed

Contraceptives Containing Drospirenone and Blood Pressure

Blood Pressure | Contraception

Brazil
Bayer

Completed

Treatment of Vasomotor Symptoms in Korean Post Menopausal Women

Vasomotor Symptoms

Korea, Republic of
Bayer

Completed

Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive Women

Hypertension | Postmenopause
University of Toledo Health Science Campus

Completed

Hemodynamic Effects of Spironolactone in Patients With Heart Failure

Congestive Heart Failure

United States
Bayer

Completed

A Study to Evaluate Inhibition of Ovulation of Two Oral Estrogen/Progestogen Regimens in Healthy, Young Females Over a Period of 3 Treatment Cycles

Contraception

Germany
Tyumen State Medical Academy

Unknown

Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants

Hyperandrogenism | Polycystic Ovarian Syndrome | Menstrual Irregularities

Russian Federation
Bayer

Completed

Study on Safety and Efficacy of an Oral Contraceptive in Long Cycles

Contraception

Netherlands, Canada, Germany
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy

Central Serous Chorioretinopathy

Austria
Second Xiangya Hospital of Central South University
Baxter Healthcare Corporation

Unknown

Residual Renal Function Preservation in Peritoneal Dialysis Patients

Chronic Renal Disease

China
Instituto Nacional de Cardiologia Ignacio Chavez

Suspended

Spironolactone and Prevention of Calcineurin Inhibitor Toxicity in Kidney Transplant Recipients

Kidney Transplant

Mexico
Bayer

Withdrawn

Clinical Study of a Conventional and Flexible Extended Oral Contraceptive of EE/DRSP With or Without Metafolin in Latin America

Contraception
Northwestern University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Metabolic Syndrome in PCOS: Precursors and Interventions

Polycystic Ovary Syndrome | Metabolic Syndrome

United States
Tel-Aviv Sourasky Medical Center

Unknown

Eplerenone For the Treatment of Chronic Central Serous Chorioretinopathy

Central Serous Chorioretinopathy

Israel
VA Salt Lake City Health Care System

Withdrawn

Spironolactone Versus Amiloride as an Add on Agent in Resistant Hypertension

Hypertension

United States
Ib Abildgaard Jacobsen

Completed

The Effect of Spironolactone on Blood Pressure in Type-2 Diabetics With Resistant Hypertension (SDHDS)

Diabetes Mellitus | Arterial Hypertension | Hypertension, Resistant to Conventional Therapy
Central Hospital, Nancy, France

Completed

Search of Biomarkers of Mineralocorticoid Receiver Activity : the Value of Neutrophil Gelatinase Associated Lipocalin (NGAL)in Serum or Urine in Human

Cardiovascular Diseases

France
Bayer

Completed

Efficacy and Safety Study for an Oral Contraceptive Containing Folate

Contraception | Neural Tube Defects | Oral Contraceptives (OC)

United States
Creighton University

Terminated

Aldosterone Blockade to Prevent Myocardial Remodeling In Patients With Controlled Essential Hypertension (Aldosterone)

Myocardial Remodeling

United States
Bayer

Completed

Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ

Contraception | Ovulation Inhibition | Contraceptives, Oral

United States
Leiden University Medical Center

Completed

Fludrocortisone and Information Processing in Healthy Volunteers

Depression

Netherlands
Yonsei University

Withdrawn

A Prospective, Single-center, Open-label, Pilot Study to Compare the Effectiveness and Safety of Diuretics Add-On Strategy in Chronic Heart Failure Patients (DIOS 1)

Congestive Heart Failure
Baylor Research Institute
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Impact of Medical and Surgical Therapy on Functional Mitral Regurgitation

Heart Diseases | Cardiovascular Diseases | Coronary Disease

United States
Massachusetts General Hospital
Bayer

Terminated

A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HS

Hidradenitis Suppurativa

United States
TC Erciyes University

Completed

Spironolactone Against Anthracycline-induced Cardiomyopathy

Anthracycline Induced Cardiotoxicity

Turkey
Denusa Wiltgen
Hospital de Clinicas de Porto Alegre; Coordenação de Aperfeiçoamento de Pessoal... and other collaborators

Completed

Pharmacogenetic Study of Different Hormone Therapies in Recent Menopause Women

Postmenopause

Brazil
University of Alabama at Birmingham
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Etiology of Sleep Apnea-related Hyperaldosteronism - BP Treatment

Obstructive Sleep Apnea | Hyperaldosteronism | Resistant Hypertension

United States
Radboud University Medical Center

Completed

Eplerenone and Extracellular Adenosine Formation (eplerenone01)

Pharmacodynamics

Netherlands
Pfizer

Terminated

A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy

Type 2 Diabetic Nephropathy

United States
University of Florida
National Heart, Lung, and Blood Institute (NHLBI); Pfizer

Completed

EWISE: Study of Eplerenone in Women With Chest Pain, Coronary Vascular Dysfunction and Evidence of Myocardial Ischemia

Ischemic Heart Disease

United States
Bayer

Completed

Study to Evaluate the Effect of Six Cycles of Treatment With a Combined Oral Contraceptive (EE 0.30 mg/DRSP 3 mg) on Quality of Life.

Healthy
Eli Lilly and Company

Completed

A Study of LY3045697 After Multiple Oral Dosing in Healthy Participants

Healthy Volunteers

Netherlands
Bayer

Completed

Assessment of the Pharmacodynamic Effect on Plasma Folate and Red Blood Cell Folate and Comparison of the Folate Metabolites During the 24 Weeks of Treatment (Yasmin + Metafolin Versus Yasmin + Folic Acid) Followed by a 20 Week Elimination Phase of Folate

Contraception

Germany
H. Lundbeck A/S

Completed

Study on Metabolic Parameters of Sertindole in Patients With Schizophrenia

Schizophrenia

China

Search clinical trials for: mineralocorticoid receptor

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations